Last reviewed · How we verify
NCT04826718
SARS-CoV-2/COVID-19 Infection Among Health Care Workers
trial testing Questionaire in SARS-CoV-2 in 400 participants. Completed in 31 January 2023.
8 September 2021
Quick facts
| Lead sponsor | Universidade de Cabo Verde |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 July 2021 |
| Primary completion | 8 September 2021 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Cabo Verde |
Drugs / interventions tested
- Questionaire
Conditions studied
- SARS-CoV-2 — all drugs for SARS-CoV-2 →
- BCG — all drugs for BCG →
- Health Care Worker — all drugs for Health Care Worker →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Universidade de Cabo Verde
Who can join
18 and older, any sex, with SARS-CoV-2 or BCG. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study finds opportunities and justifications, taking into consideration that the nature of professional practice in health needs scientific evidence resulting from systematic and systemic studies to strengthen the basis for the decisions made to have an impact on various levels, from the patient to health management itself. In addition, Cabo Verdean authorities may benefit from new evidence obtained by this study. It intends, in a growing number of health professionals exposed or infected with SARS-CoV-2, in the different health structures of the country, to contribute to substantiate a better perception of the problem and the required solutions. Therefore, assessing the potential risk factors for SARS-CoV-2 infection among healthcare workers will be essential to characterize virus transmission, preventing future infections in them and providing the associated healthcare. Due to the advances and important changes described, questions arise that guide this research and allow us to identify the problem.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.
Du J, Su Y, Wang R, Dong E, et al · · 2023 · cited 6× · PMID 36798128 · DOI 10.3389/fimmu.2023.1118378
Verify or expand the search:
- PubMed search for NCT04826718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionaire
Trials testing the same drug.
- NCT07003724 — Patient's Knowledge About AI in Dentistry · not yet recruiting
- NCT06810479 — A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea · NA · not yet recruiting
- NCT05142150 — Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE) · recruiting
- NCT04816357 — Identification of Endometriosis and Migraine Criteria in Women With the Comorbidity of Both Conditions in Comparison Wit · completed
- NCT04537117 — Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19 · completed
Other recruiting trials for SARS-CoV-2
Currently open trials in the same condition.
- NCT07266558 — A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without Hig · Phase 4 · recruiting
- NCT06684379 — Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A · Phase 1, PHASE2 · recruiting
- NCT06585241 — A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations · Phase 4 · recruiting
- NCT05876377 — Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data · active not recruiting
- NCT05799651 — Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults · Phase 1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04826718 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade de Cabo Verde
- Last refreshed: 9 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04826718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing